Trial site
Institut Paoli-Calmette
- 9running trials
- 3closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia2 trials
- Kidney cancer2 trials
- Neuroendocrine tumours2 trials
- Liver and biliary tract cancer1 trial
- Mantle cell lymphoma1 trial
- Multiple myeloma1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Prostate cancer1 trial
- Sarcoma1 trial
- Phase
- Phase 24 trials
- Phase 34 trials
- Phase 11 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Suspended1 trial
- Terminated1 trial
- Lead sponsor
- French Innovative Leukemia Organisation2 trials
- Centre Francois Baclesse1 trial
- GERCOR - Multidisciplinary Oncology Cooperative Group1 trial
- Grupo Espanol de Tumores Neuroendocrinos1 trial
- Hoffmann-La Roche1 trial
- and 7 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Bintrafusp Alfa and Doxorubicin Hydrochloride in Treating Patients With Advanced Sarcoma
Active, not recruiting
Recruiting
Active, not recruiting
Preemptive Therapy for High Risk Chronic Lymphoid Leukemia Stage A
Active, not recruiting
Nonfunctioning Small (≤2 cm) Neuroendocrine Pancreatic Incidentaloma
Recruiting
UroCCR Database: French Research Network for Kidney Cancer -UroCCR
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Kidney cancer2 recruiting
- Liver and biliary tract cancer1 recruiting
- Neuroendocrine tumours1 recruiting
Closed trials
Terminated
A Study of TAS0612 in Participants With Advanced or Metastatic Solid Tumor Cancer
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026